WELL Health Technologies Corp. WELL.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.95% | 50.18% | 49.49% | 32.91% | 22.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.95% | 50.18% | 49.49% | 32.91% | 22.59% |
| Cost of Revenue | 26.48% | 35.28% | 37.82% | 32.06% | 27.89% |
| Gross Profit | 52.31% | 73.48% | 67.36% | 34.10% | 15.57% |
| SG&A Expenses | 34.55% | 38.61% | 31.12% | 26.38% | 19.64% |
| Depreciation & Amortization | 23.63% | 33.65% | 27.52% | 32.25% | 22.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.91% | 36.26% | 34.78% | 30.17% | 24.67% |
| Operating Income | 1,527.20% | 558.34% | 426.99% | 256.43% | -70.00% |
| Income Before Tax | 115.36% | 194.18% | -26.40% | -139.01% | -185.24% |
| Income Tax Expenses | 141.63% | 103.98% | 105.12% | 158.11% | 20.45% |
| Earnings from Continuing Operations | 113.87% | 261.94% | -80.55% | -142.52% | -176.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -843.89% | -970.45% | -452.26% | 157.86% | 90.63% |
| Net Income | 103.02% | 212.97% | -117.88% | -138.89% | -185.10% |
| EBIT | 1,527.20% | 558.34% | 426.99% | 256.43% | -70.00% |
| EBITDA | 146.36% | 419.20% | 522.17% | 65.62% | -5.34% |
| EPS Basic | 102.93% | 222.60% | -118.50% | -135.61% | -183.14% |
| Normalized Basic EPS | 94.12% | 116.85% | 116.70% | 81.62% | 2.21% |
| EPS Diluted | 102.39% | 199.59% | -124.27% | -140.26% | -185.95% |
| Normalized Diluted EPS | 93.46% | 116.37% | 116.37% | 80.47% | -0.34% |
| Average Basic Shares Outstanding | 4.47% | 4.98% | 5.33% | 0.27% | 0.88% |
| Average Diluted Shares Outstanding | 4.37% | 4.82% | 4.08% | -0.86% | -0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |